Accéder au contenu
Merck
Toutes les photos(2)

Documents

50787

Supelco

Bisoprolol

analytical standard

Synonyme(s) :

1-{4-{[2-(1-Methylethoxy)ethoxy]methyl}phenoxy}-3-[(1-methylethyl)amino]-2-propanol

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme
Toutes les photos(2)

About This Item

Formule empirique (notation de Hill):
C18H31NO4
Numéro CAS:
66722-44-9
Poids moléculaire :
325.44
Numéro MDL:
MFCD00865795
Code UNSPSC :
41116107
ID de substance PubChem :
329757631
Nomenclature NACRES :
NA.24

Qualité

analytical standard

Pureté

≥97.0% (HPLC)

Durée de conservation

limited shelf life, expiry date on the label

Technique(s)

HPLC: suitable
gas chromatography (GC): suitable

Application(s)

forensics and toxicology
pharmaceutical (small molecule)

Format

neat

Température de stockage

2-8°C

Chaîne SMILES 

CC(C)OCCOCC1=CC=C(OCC(O)CNC(C)C)C=C1

InChI

1S/C18H31NO4/c1-14(2)19-11-17(20)13-23-18-7-5-16(6-8-18)12-21-9-10-22-15(3)4/h5-8,14-15,17,19-20H,9-13H2,1-4H3

Clé InChI

VHYCDWMUTMEGQY-UHFFFAOYSA-N

Informations sur le gène

human ... ADRB1(153)

Catégories apparentées

Application

Refer to the product′s Certificate of Analysis for more information on a suitable instrument technique. Contact Technical Service for further support.

Pictogrammes

Health hazardExclamation mark
GHS08,GHS07

Mention d'avertissement

Warning

Mentions de danger

H302,H361fd,H373

Classification des risques

Acute Tox. 4 Oral - Repr. 2 - STOT RE 2

Organes cibles

Heart

Code de la classe de stockage

10 - Combustible liquids

Classe de danger pour l'eau (WGK)

WGK 1

Point d'éclair (°F)

Not applicable

Point d'éclair (°C)

Not applicable

Choose from one of the most recent versions:

Certificats d'analyse (COA)

Lot/Batch Number
BCCL9762
BCCK9254
BCCG9195
BCCF5130
BCCD9646

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

Les clients ont également consulté

Slide 1 of 9

1 of 9

Nebivolol hydrochloride ≥98% (HPLC)

Sigma-Aldrich

N1915

Nebivolol hydrochloride

Atenolol ≥98% (TLC), powder

Sigma-Aldrich

A7655

Atenolol

Carvedilol ≥98% (HPLC), solid

Sigma-Aldrich

C3993

Carvedilol

Zolpidem ≥98% (HPLC), solid

Sigma-Aldrich

Z103

Zolpidem

Metoprolol tartrate European Pharmacopoeia (EP) Reference Standard

M1830000

Metoprolol tartrate

Nadolol analytical standard

Supelco

N1892

Nadolol

Salbutamol

Sigma-Aldrich

S8260

Salbutamol

Forskoline analytical standard

Supelco

93049

Forskoline

Isoprenaline hydrochloride

Sigma-Aldrich

I5627

Isoprenaline hydrochloride

Syunsuke Yamamoto et al.
Journal of pharmaceutical sciences, 106(9), 2787-2794 (2017-03-21)
Although several mathematical models have been reported for the estimation of human plasma concentration profiles of drug substances after dermal application, the successful cases that can predict human pharmacokinetic profiles are limited. Therefore, the aim of this study is to
Gyung Min Park et al.
Diabetes & metabolism journal, 44(3), 470-479 (2019-11-27)
There are limited data on the impact of diabetes control on the risk of subclinical coronary atherosclerosis. We analyzed 6,434 consecutive asymptomatic individuals without previous history of coronary artery disease who underwent coronary computed tomographic angiography (CCTA) (mean age, 53.7±7.6
Peter C Rockers et al.
The Lancet. Global health, 7(4), e492-e502 (2019-02-26)
Novartis Access is a Novartis programme that offers a portfolio of non-communicable disease medicines at a wholesale price of US$1 per treatment per month in low-income and middle-income countries. We evaluated the effect of Novartis Access in Kenya, the first
Olivier Ghekiere et al.
The international journal of cardiovascular imaging, 35(3), 559-568 (2018-10-05)
Only one-third of intermediate-grade coronary artery stenosis (i.e. 40-70% diameter narrowing) causes myocardial ischemia, requiring most often additional invasive work-up with invasive fractional flow reserve (FFR). To evaluate the correlations between FFR estimates derived from computed tomography (FFRCT) and adenosine
Lauri Suojanen et al.
Basic & clinical pharmacology & toxicology, 121(2), 130-137 (2017-03-04)
Treatment with beta-blockers appears to show inferior reduction in central versus peripheral blood pressure. We aimed to examine simultaneous changes in central and peripheral blood pressure, vascular resistance, cardiac function and arterial stiffness during beta-blockade. Haemodynamics were investigated after 3
Afficher tous les articles scientifiques apparentés

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique